Search Results - "Jackeline O. Gomes"

Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trial by Zampieri, Fernando G., Westphal, Glauco Adrieno, Santos, Maria Adelaide Dos, Gomes, Samara P.C., Gomes, Jackeline O., Negrelli, Karina L., Santos, Renato H.N., Ishihara, Luciana M., Miranda, Tamiris A., Laranjeira, Ligia N., Valeis, Nanci, Santucci, Eliana Vieira, de Souza Dantas, Vicente Cés, Gebara, Otávio, Cohn, Danny M., Buchele, Gustavo, Janiszewski, Mariano, de Freitas, Flávio Geraldo, Dal-Pizzol, Felipe, de Matos Soeiro, Alexandre, Berti, Isabele Ribeiro, Germano, Almir, Schettini, Daniel Almeida, Rosa, Regis G., Falavigna, Maicon, Veiga, Viviane C., Azevedo, Luciano C.P., Damiani, Lucas P., Machado, Flávia R., Cavalcanti, Alexandre B.

“…To assess the effect of antisense therapy to block kallikrein-kinin pathway in COVID-19 patients. Randomized, placebo-controlled, double blind, controlled…”
Get full text

Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil by Castilho, Jessica L, Escuder, Maria M, Veloso, Valdiléa, Gomes, Jackeline O, Jayathilake, Karu, Ribeiro, Sayonara, Souza, Rosa A, Ikeda, Maria L, Alencastro, Paulo R, Tupinanbas, Unai, Brites, Carlos, McGowan, Catherine C, Grangeiro, Alexandre, Grinsztejn, Beatriz

“…Introduction People living with HIV (PLHIV) on antiretroviral therapy (ART) experience high rates of non‐communicable diseases (NCDs). These co‐morbidities…”
Get full text

Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial by Maia, Israel S., Marcadenti, Aline, Veiga, Viviane C., Miranda, Tamiris A., Gomes, Samara P.C., Carollo, Mariana B.S., Negrelli, Karina L., Gomes, Jackeline O., Tramujas, Lucas, Abreu-Silva, Erlon O., Westphal, Glauco A., Fernandes, Ruthy P., Horta, Jacques G.A., Oliveira, Deborah C., Flato, Uri A.P., Paoliello, Ricardo C.R., Fernandes, Camilo, Zandonai, Cássio L., Coelho, Juliana C., Barros, Waldemar C., Lemos, Juliana C., Bolan, Renata S., Dutra, Marcela M., Gebara, Otavio C.E., Lopes, Ana T.A., Alencar Filho, Meton S., Arraes, Jussara A., Hamamoto, Victor A., Hernandes, Mauro E., Golin, Nicole A., Santos, Tiago M., Santos, Renato H.N., Damiani, Lucas P., Zampieri, Fernando G., Gesto, João, Machado, Flávia R., Rosa, Régis G., Azevedo, Luciano C.P., Avezum, Alvaro, Lopes, Renato D., Souza, Thiago M.L., Berwanger, Otávio, Cavalcanti, Alexandre B.

“…Repurposed drugs for treatment of new onset disease may be an effective therapeutic shortcut. We aimed to evaluate the efficacy of repurposed antivirals…”
Get full text

Sa1719 – Comparison of Two Cut-Off Values of the Fecal Immunochemical Test During an Organized Colorectal Cancer Screening by Safatle-Ribeiro, Adriana V., Sorbello, Mauricio P., Pfuetzenreiter, Vinicius, Bastos, Victor R., Cohen, Diane D., Souza, Afonso H. Silva e, Hashimoto, Claudio L., Franco, Joel L., Gomes, Jackeline O., Alves, Venancio A., Cecconello, Ivan, Nahas, Sergio C., Neto, Jose Eluf, Ribeiro, Ulysses

Get full text

Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trialResearch in context by Israel S. Maia, Aline Marcadenti, Viviane C. Veiga, Tamiris A. Miranda, Samara P.C. Gomes, Mariana B.S. Carollo, Karina L. Negrelli, Jackeline O. Gomes, Lucas Tramujas, Erlon O. Abreu-Silva, Glauco A. Westphal, Ruthy P. Fernandes, Jacques G.A. Horta, Deborah C. Oliveira, Uri A.P. Flato, Ricardo C.R. Paoliello, Camilo Fernandes, Cássio L. Zandonai, Juliana C. Coelho, Waldemar C. Barros, Juliana C. Lemos, Renata S. Bolan, Marcela M. Dutra, Otavio C.E. Gebara, Ana T.A. Lopes, Meton S. Alencar Filho, Jussara A. Arraes, Victor A. Hamamoto, Mauro E. Hernandes, Nicole A. Golin, Tiago M. Santos, Renato H.N. Santos, Lucas P. Damiani, Fernando G. Zampieri, João Gesto, Flávia R. Machado, Régis G. Rosa, Luciano C.P. Azevedo, Alvaro Avezum, Renato D. Lopes, Thiago M.L. Souza, Otávio Berwanger, Alexandre B. Cavalcanti

“…Background: Repurposed drugs for treatment of new onset disease may be an effective therapeutic shortcut. We aimed to evaluate the efficacy of repurposed…”
Get full text